Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...

Software engineers are increasingly seeking structured pathways to transition into machine learning roles as companies expand ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation ...

The comprehensive review Michael Alford promised when FSU announced it would retain Mike Norvell is now in full swing. Here's ...

US POINTER, a healthy lifestyle intervention, helped participants improve blood pressure regulation of blood flow to the ...

Structure Therapeutics, Inc. Sponsored ADR ( ($GPCR) ) has shared an announcement. On December 8, 2025, Structure Therapeutics announced positive ...

Strengthening Financial Strategy for Mineral Exploration in Texas DALLAS, TEXAS / ACCESS Newswire / December 8, 2025 / First ...

Structure Therapeutics (GPCR) announced positive topline data from the ACCESS clinical program of aleniglipron for the treatment of people living ...

HAWKs is intersecting childhood enrichment, youth mental wellness and environmental stewardship bringing children back to the ...

Investing.com -- Structure Therapeutics Inc ADR (NASDAQ:GPCR) stock soared 28.8% in premarket trading Monday after the company announced positive topline data from its ACCESS clinical program for ...

Peachtree Wellness Solutions has announced its expansion of mental health services in Atlanta, Georgia, by widening its ...

The MARK Passenger Rail Commission held its inaugural meeting on December 5, 2025, at Racine City Hall, where members adopted ...